Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

2(29%)

Results Posted

33%(1 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_1

57%

Ph phase_4

14%

Ph not_applicable

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

4(57.1%)

Phase 4Post-market surveillance

1(14.3%)

N/ANon-phased studies

2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Terminated(1)

Other(1)

Detailed Status

Completed3

unknown1

Active, not recruiting1

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 14 (57.1%)

Phase 41 (14.3%)

N/A2 (28.6%)

Trials by Status

unknown114%

active_not_recruiting114%

recruiting114%

terminated114%

completed343%

Recent Activity

2 active trials

Showing 5 of 7

recruitingnot_applicable

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

NCT06382818

active_not_recruitingphase_1

Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)

NCT04280536

completedphase_1

A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants

NCT06640920

terminatednot_applicable

Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases

NCT03189381

completedphase_1

Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer

NCT03430479

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT06382818Not Applicable

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

Recruiting

NCT04280536Phase 1

Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)

Active Not Recruiting

NCT06640920Phase 1

A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants

Completed

NCT03189381Not Applicable

Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases

Terminated

NCT03430479Phase 1

Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer

Completed

NCT04389775Phase 1

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants

Completed

NCT02910375Phase 4

Golimumab Dried Blood Spot Analysis

Unknown

All 7 trials loaded

Drug Details

Intervention Type: RADIATION
Total Trials: 7